Deborah Layton

Prescription-event monitoring and reporting of adverse drug reactions

Emma Heeley, Jane Riley, Deborah Layton et al. · The Lancet · 2001 · 127 citations

Drug Safety, Drug Hypersensitivity, Drug Information System +7

Causal Association in Pharmacovigilance and Pharmacoepidemiology

Saad Shakir, Deborah Layton · Drug Safety · 2002 · 120 citations

Drug Safety, Behavioral Pharmacology, Causal Association +6

Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding?

Deborah Layton, David W. Clark, Gillian Pearce et al. · European Journal of Clinical Pharmacology · 2001 · 70 citations

Psychiatry, Medicine, Psychotropic Medication +13

Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia

Deborah Layton, Scott Harris, Lynda V. Wilton et al. · Journal of Psychopharmacology · 2005 · 67 citations

Elderly Patients, Cerebrovascular Disease, Pharmacotherapy +23

Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data

Deborah Layton · British journal of rheumatology · 2003 · 55 citations · Full text